Biologic Specimen and Data Repository Information Coordinating Center
Home > Proprietary Studies > BMT CTN 0402

Resources Available

Specimens Only

A Phase III Randomized, Multicenter Trial Comparing Sirolimus/Tacrolimus with Tacrolimus/Methotrexate as Graft-Versus-Host Disease (GVHD) Prophylaxis After HLA-Matched, Related Peripheral Blood Stem Cell Transplantation (BMT CTN 0402)

Website: https://web.emmes.com/study/bmt2
Parent Study Contact: Alan Howard, ahoward@nmdp.org
Study Type: Clinical Trial
Prepared on May 31, 2012
Consent: Restricted Consent
Consent Restrictions: For protocol use only
Commercial Use Restrictions: No
Collection Type: Proprietary Study - See bottom of this webpage for request information

Objectives

The primary objective is to compare the rates of 114-day Grades II-IV acute GVHD free survival between patients in the two study arms from the time of randomization using an intent-to-treat analysis.

Interested parties can contact Alan Howard for further details about specimen availability.


Interested parties should review the Proprietary Study application process before they begin. Requests for Proprietary Studies must be approved by the Parent Study before they can be processed by BioLINCC. Contact information for the Parent Study is provided at the top of this webpage. Upon Parent Study approval, click the Request button to start a request through BioLINCC.